Key result
A 27-year-old man with malignant neurocardiogenic syncope experienced a prolonged 24-second asystole during a head-up tilt test despite treatment with oral disopyramide 150 mg daily.
Case Report (n=1)
No
This case highlights the occurrence of malignant cardioinhibitory neurocardiogenic syncope with prolonged asystole during a head-up tilt test despite treatment with oral disopyramide.
Answers are grounded in this paper and cite their sources.
This case should not change disopyramide use; it leaves open questions on efficacy in malignant neurocardiogenic syncope.
A 27 year‐old man was taken to our emergency room after collapsing during a conference. The patient had a history of syncope twice since age 15. A marked sinus bradycardia and asystole were induced causing the patient to collapse when tested to stand up in the emergency room. Cardioinhibitory type neurocardiogenic syncope was considered to be the cause of the syncope. Therefore the patient was treated with oral disopyramide at a daily dose of 150 mg. Three weeks later, a head‐up tilt test was performed for evaluation of drug effectiveness. However, a prolonged asystole for 24 seconds due to sinus arrest without escape beat was induced 7 minutes after starting the tilt at 80 degrees. Although the tilt table was returned to the flat position immediately, it took an additional 30 seconds for complete recovery of the patient's consciousness. Malignant cardioinhibitory type neurocardiogenic syncope with a prolonged asystole such as was found in this patient has rarely been observed. Treatment options should be discussed if the patient refuses pacemaker implantation.
No takes yet. Share an insight, caveat, or question.
Tokano et al. (2008) conducted a case report in Malignant neurocardiogenic syncope (n=1). Oral disopyramide and head-up tilt test was evaluated on Induction of asystole during head-up tilt test. A 27-year-old man with malignant neurocardiogenic syncope experienced a prolonged 24-second asystole during a head-up tilt test despite treatment with oral disopyramide 150 mg daily.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: